33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 3, randomized, open-label study of epacadostat plus pembrolizumab, pembrolizumab monotherapy, and the EXTREME regimen as first-line treatment for recurrent/metastatic head and neck squamous cell carcinoma (R/M SCCHN): ECHO-304/KEYNOTE-669
    Meeting Abstract

    Cohen, E. E. W.; Rischin, D.; Pfister, D. G.; Vermorken, J. B.; Zhao, Y.; Gowda, H.; Ge, J. Y.; Jin, F.; Harrington, K. J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma
    Meeting Abstract

    Batlevi, C. L.; De Frank, S.; Stewart, C.; Hamlin, P. A.; Matasar, M. J.; Gerecitano, J. F.; Moskowitz, A. J.; Hamilton, A. M.; Zelenetz, A. D.; Drullinsky, P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Immunotherapy awareness in the oncology patient population: An Irish hospital experience
    Meeting Abstract

    Aleem, U.; Grant, C.; Gallagher, D. J.; Sukor, S.; Kennedy, J.; Kelleher, C. F.; Lowery, M. A.; O'Donnell, D. M.; Gleeson, J.; Glennon, L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Patient (pt)-reported function and symptoms in APHINITY: A randomized comparison of chemotherapy (C) + trastuzumab (H) + placebo (Pla) versus C + H + pertuzumab (P) as adjuvant therapy in pts with HER2-positive early breast cancer (EBC)
    Meeting Abstract

    Baselga, J.; Petersen, J. A.; Clark, E.; Barton, C.; Restuccia, E.; Procter, M. J.; Sonnenblick, A.; Fumagalli, D.; Parlier, D.; Arahmani, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The Memorial Sloan Kettering (MSK) electronic informed consent (eIC) platform for clinical trials: An operational model and suite of tools for obtaining informed consent, and managing consent documents
    Meeting Abstract

    Buckley, M. T.; Lengfellner, J. M.; Koch, M. J.; Pacheco, H. O.; Hoidra, C.; Damron, D. J.; Cambria, R.; Rodavitch, A.; Sabbatini, P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Electronic patient-reported outcomes (ePRO) in survivorship practice
    Meeting Abstract

    Corcoran, S.; Thom, B.; Decker, K.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Impact of cancer survivorship care plans (SCPs) on health outcomes and health care delivery: A systematic review
    Meeting Abstract

    Jacobsen, P. B.; Derosa, A. P.; Henderson, T. O.; Mayer, D.; Moskowitz, C. S.; Paskett, E. D.; Rowland, J. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase Ib open-label, dose escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in combination with abiraterone or enzalutamide in metastatic castrate-resistant prostate cancer
    Meeting Abstract

    Vaishampayan, U. N.; Narayan, V.; Wise, D.; Lang, J. M.; Lowentritt, B. H.; Mellado, B.; Carles, J.; Saez, M. I.; Abida, W.; Taplin, M. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A survey of colorectal cancer (CRC) survivorship practices in Ireland, and implementation of a survivorship care plan (SCP) pilot program
    Meeting Abstract

    Keane, F.; Greally, M.; Power, D. G.; Leonard, G. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tailored survivorship care plans for head and neck cancer patients
    Meeting Abstract

    Salner, A. L.; Baxi, S. S.; Fortier, E.; Salz, T.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save